VRTX

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) FY 2026 Corporate Conference

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Sec Form 10K

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Sec Form 8K

Vertex Pharmaceuticals reported solid financial results for the fourth quarter of 2025, driven by continued demand for its cystic fibrosis…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 Earnings Release

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2025 Earnings Conference

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q2 2025 Earnings Call dated Aug. 04, 2025 Corporate Participants: Susie Lisa — Senior Vice…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2025 Earnings Call dated Nov. 03, 2025 Corporate Participants: Susie Lisa — Senior Vice…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14%…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2…